Cargando…

Safety of psychotropic medications in people with COVID-19

INTRODUCTION: People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but the underlying medical condition and possible interaction with medical treatments might pose serious safety issues. OBJECTIVES: To review the direct and indirect evidence on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostuzzi, G., Papola, D., Gastaldon, C., Barbui, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471348/ http://dx.doi.org/10.1192/j.eurpsy.2021.274

Ejemplares similares

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants
por: Gastaldon, C., et al.
Publicado: (2023)

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis
por: Papola, D., et al.
Publicado: (2021)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents
por: Gastaldon, C., et al.
Publicado: (2023)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market
por: Gastaldon, C., et al.
Publicado: (2021)

Psychotropic medication for challenging behavior in people with learning disabilities in Qatar
por: Eltorki, Y., et al.
Publicado: (2021)

Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
por: Papola, Davide, et al.
Publicado: (2020)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
por: Gastaldon, Chiara, et al.
Publicado: (2022)

Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses
por: Papola, Davide, et al.
Publicado: (2020)

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

The interactions between COVID-19 drugs and psychotropic agents
por: Hiemke, C.
Publicado: (2021)

QT Prolongation: Psychotropic medication versus illicit drugs
por: Florian, A., et al.
Publicado: (2022)

Psychotropics and COVID-19: An analysis of safety and prophylaxis
por: Javelot, H., et al.
Publicado: (2021)

Glaucoma and Psychotropics
por: Cavaco, T., et al.
Publicado: (2022)

Psychotropic drug repurposing for COVID-19: a systematic review
por: Isayeva, U., et al.
Publicado: (2022)

Effects of psychotropic medications on pregnancy and breast feeding
por: LAD, ASHWINI, et al.
Publicado: (2022)

Misuse of psychotropic medications among hospitalized patients
por: Azraf, F., et al.
Publicado: (2023)

CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials
por: Papola, Davide, et al.
Publicado: (2023)

Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
por: Yingyang, Zhang, et al.
Publicado: (2021)

Resilience of people with a history of mental disorder during the COVID-19 pandemic: a 2-years longitudinal prospective study
por: Pinucci, I., et al.
Publicado: (2023)

Cognitive decline and psychotropic drugs use in elderly people with mental disorders
por: De Oliveira, K. Cestari, et al.
Publicado: (2021)

Pro Re Nata Use of Psychotropic Medications in Assisted Living
por: Carder, Paula, et al.
Publicado: (2020)

Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare
por: Ostuzzi, Giovanni, et al.
Publicado: (2013)

Specificities of the Use of Psychotropic Drugs in Bariatric Surgery
por: Fernandes Santos, C., et al.
Publicado: (2022)

Editorial: Safety and side effects of psychotropic medications
por: de Filippis, Renato, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on psychotropic medication uptake in Northern Ireland: a population-wide trend analysis
por: Kent, Lisa, et al.
Publicado: (2021)

PS38. Psychotropic medication for bipolar patients in the psychiatric acute inpatient unit.
por: Sasamori, Hiroki, et al.
Publicado: (2016)

Correlates of Pain, Opioid Use, and Psychotropic Medications Among Older African Americans
por: Cobb, Sharon, et al.
Publicado: (2020)

Pharmacokinetic interactions of psychotropic medications in patients with schizophrenia suffering from atypical mycobacterial infections
por: Sabaté, M. Betriu, et al.
Publicado: (2021)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Antipsychotic and Psychotropic Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

Psychotropic medication prescribing during the COVID-19 pandemic
por: Hirschtritt, Matthew E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6a3fvo0d0dicqukoijrj0iplsq